Showing results (511-520 of 235,558) with videos related to
Sort By:
Pageof 23,556
Journal of Nanoscience and Nanotechnology|October 20, 2006
Intracellular delivery of cysteine protease inhibitor cystatin by polymeric nanoparticlesMateja Cegnar, Janko Kos, Julijana KristlExpert Opinion on Biological Therapy|January 17, 2007
Cysteine cathepsins: regulators of antitumour immune responseNatasa Obermajer, Bojan Doljak, Janko KosSeminars in Cancer Biology|August 1, 2018
Cysteine cathepsins: Their biological and molecular significance in cancer stem cellsAnja Pišlar, Anahid Jewett, Janko Kos3 Biotech|July 8, 2017
Higher fungi are a rich source of L-amino acid oxidasesGašper Žun, Janko Kos, Jerica SabotičThe Journal of Biological Chemistry|November 28, 2008
The Klebsiella pneumoniae O2a antigen defines a second mechanism for O antigen ATP-binding cassette transportersVeronica Kos, Leslie Cuthbertson, Chris WhitfieldCell Motility and the Cytoskeleton|August 12, 2009
Cysteine protease-mediated cytoskeleton interactions with LFA-1 promote T-cell morphological changesZala Jevnikar, Natasa Obermajer, Janko KosThe Biochemical Journal|January 20, 2012
γ-Enolase C-terminal peptide promotes cell survival and neurite outgrowth by activation of the PI3K/Akt and MAPK/ERK signalling pathwaysAnja Hafner, Nataša Obermajer, Janko KosDisability and Rehabilitation|April 8, 2011
Mobility and functional outcomes after femoral neck fracture surgery in elderly patients: a comparison between hemiarthroplasty and internal fixationNataša Kos, Helena Burger, Gaj VidmarImmunology|October 10, 1998
Involvement of protein kinase C-delta in CD28-triggered cytotoxicity mediated by a human leukaemic cell line YTF J Kos, H D BearEuropean Journal of Cancer (Oxford, England : 1990)|December 25, 2007
Accessibility to targeted oncology drugs in Slovenia and selected European countriesMitja Kos, Marko Obradovic, Ales MrharPageof 23,556